Bioanalytical method development, pharmacokinetics, and toxicity studies of paromomycin and paromomycin loaded in

Wahid Khan1, Shyam S Sharma, Neeraj Kumar

  • 1Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), S.A.S., Nagar, India.

Insights

New albumin microspheres effectively deliver paromomycin (PM) to target intracellular leishmania parasites. This formulation shows improved safety and efficacy compared to traditional PM injections for visceral leishmaniasis treatment.

Area of Science:

  • Pharmacology
  • Drug Delivery
  • Parasitology

Background:

  • Leishmania parasites reside intracellularly within macrophages, evading host defenses and antibiotics like paromomycin (PM).
  • Targeting intracellular parasites requires specialized drug delivery systems to enhance therapeutic efficacy.

Purpose of the Study:

  • To develop and evaluate paromomycin-loaded albumin microspheres (PM-MS) for improved targeting of intracellular leishmania parasites.
  • To assess the pharmacokinetic profile and safety of the novel PM-MS formulation.

Main Methods:

  • Development of PM-loaded albumin microspheres (PM-MS).
  • Establishment and validation of a sensitive bioanalytical method for quantifying PM in rat plasma.
  • Pharmacokinetic studies comparing PM and PM-MS administered via intramuscular and intravenous routes.
  • Acute and subacute toxicity evaluations of PM and PM-MS formulations.

Main Results:

  • A sensitive bioanalytical method with a quantification limit of 40 ng/ml was developed.
  • PM-MS administration resulted in an approximately 80% reduction in C(max) compared to other formulations.
  • Toxicity studies revealed no adverse effects for PM-MS at 90 mg/kg, unlike PM intramuscular injection which increased blood urea and BUN levels.

Conclusions:

  • PM-MS formulation demonstrates enhanced pharmacokinetic properties and a favorable safety profile.
  • The developed PM-MS represents a promising alternative to current paromomycin intramuscular injections for visceral leishmaniasis treatment.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...